Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (641-650 of 666) with videos related to

Pageof 67
Sort By:
The ISME Journal|January 5, 2019
Nitric oxide production and antioxidant function during viral infection of the coccolithophore Emiliania huxleyiBrittany M Schieler, Megha V Soni, Christopher M Brown, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
The Biochemical Journal|May 13, 1998
Characterization of the stress-inducing effects of homocysteineP A Outinen, S K Sood, P C Liaw, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The New England Journal of Medicine|February 9, 1989
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarctionA G Turpie, J G Robinson, D J Doyle, et al.
Journal of Internal Medicine|March 6, 1998
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic processP S Wells, J Hirsh, D R Anderson, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
The New England Journal of Medicine|November 18, 2000
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study GroupP Brill-Edwards, J S Ginsberg, M Gent, et al.
Pageof 67

Showing results (641-650 of 666) with videos related to

Sort By:
Pageof 67
The ISME Journal|January 5, 2019
Nitric oxide production and antioxidant function during viral infection of the coccolithophore Emiliania huxleyiBrittany M Schieler, Megha V Soni, Christopher M Brown, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
The Biochemical Journal|May 13, 1998
Characterization of the stress-inducing effects of homocysteineP A Outinen, S K Sood, P C Liaw, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The New England Journal of Medicine|February 9, 1989
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarctionA G Turpie, J G Robinson, D J Doyle, et al.
Journal of Internal Medicine|March 6, 1998
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic processP S Wells, J Hirsh, D R Anderson, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
The New England Journal of Medicine|November 18, 2000
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study GroupP Brill-Edwards, J S Ginsberg, M Gent, et al.
Pageof 67